Home » Topics » BioWorld Science

BioWorld Science
RSS

Defective gamma fibrinogen crosslinking exacerbates liver injury

July 18, 2022

Thrombogenic effects of allosteric SHP2 inhibitor SHP-099

July 18, 2022

Murine model shows fibrin alpha crosslinking impairment behind thromboembolism

July 18, 2022

Enterome and Nestle Health Science collaborate to tackle food allergies and IBD

July 18, 2022

PCYOX1 identified as new target for antithrombotic therapy

July 18, 2022

Merck & Co. synthesizes orexin OX2 receptor agonists

July 18, 2022

Pfizer describes new IL-2 production inhibitors

July 18, 2022

Janssen Pharmaceutica presents new Mcl-1 inhibitors

July 18, 2022

Novartis divulges new cGAS inhibitors

July 18, 2022

Sunshine Lake Pharma patents new chymotrypsin inhibitors

July 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...